Dr Desiree Holzer, | |
523 N 3rd St, Brainerd, MN 56401-3054 | |
(218) 829-2861 | |
Not Available |
Full Name | Dr Desiree Holzer |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 523 N 3rd St, Brainerd, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023283066 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 54253 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Desiree Holzer, 523 N 3rd St, Brainerd, MN 56401-3054 Ph: (218) 829-2861 | Dr Desiree Holzer, 523 N 3rd St, Brainerd, MN 56401-3054 Ph: (218) 829-2861 |
News Archive
Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna Aneurysm Embolization System received CE Mark for the treatment of patients with brain aneurysms.
While AHIMA continues to applaud federal government support for the ideal of protecting patients' health information rights, the proposed rule making for HIPAA privacy, security and enforcement by HHS has a number of requirements that we do not believe the industry is ready to undertake; especially as it gears up for Meaningful Use. Today AHIMA is releasing its recommendations to the HHS Office of Civil Rights (OCR) that speak to the issues we believe are most critical to the patients of America, the healthcare industry and the best practice of health information management.
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of active and convalescent COVID-19 treatment.
New research has dispelled the myth that by losing weight women can also lose the "orange peel" effect of cellulite.
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
› Verified 7 days ago
Mr. Mark Christopher Patnode, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 | |
Neil Saley, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2024 S 6th St, Brainerd, MN 56401 Phone: 218-855-5431 | |
Mr. Jeffrey Sam Porter, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 | |
Dr. Michael Haarstad, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 | |
Charles William Andres, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 11483 White Pine Rd Sw, Brainerd, MN 56401 Phone: 218-829-1454 | |
Robert P Bacon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-828-7494 Fax: 218-828-7611 |